Dexamethasone is basically a steroid that is used to treat different conditions including immune system, hormone, arthritis, blood, hormone, allergic reaction, eye condition, and certain skin conditions as well. It is also used to treat the bowel disorders, breathing issues, and few cancers. The said steroid is applied as a test for Cushing’s syndrome (adrenal gland disorder). This type of medication is a corticosteroid hormone, which decreases the body’s natural defensive response and also decreases the symptoms like allergic-related reaction and swelling. Using dexamethasone is usually recommended to be consumed through mouth (orally) or as directed by the patient’s physician.
The market growth can be attributed to several factors, which has led to its wide-scale adoption. Growing prevalence of asthma & allergic diseases and increasing demand of dexamethasone drug worldwide for the treatment of COVID-19 are anticipated to fuel the demand of dexamethasone in the coming years. However, issues with quality control and possibility of shortage of drug are likely to restrain the market growth to a certain extent.
Dexamethasone Market Prominent Players:
Some of the prominent players operating in the dexamethasone market include Allergan, Ocular Therapeutix, Inc., Zydus Cadila, Cadila Pharmaceuticals, Fresenius Kabi USA, GLS pharma ltd, Pfizer Limited, Novartis AG, Mylan N.V. Sun Pharmaceutical Industries Ltd., among others.
No comments:
Post a Comment